Antisphingolipid antibodies in the sera of leprosy patients

Leprosy Review

Volumn 67, Issue 2, 1996, Pages 95-103

  Vemuri, N ^a   Viera, L M ^a   Taneja, K K ^b   Gangal, S V ^b   Mukherjee, R ^a,c  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^c Microbiology Division   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CERAMIDE; GALACTOSYLCERAMIDE; SPHINGOLIPID;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; SERODIAGNOSIS;

EID: 0029952012     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19960010     Document Type: Article

References (22)

1. Bloom BR, Godal T. Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis, 1983; 5: 765-780.
2. Job CR. Mycobacterium leprae in nerve lesions in lepromatous leprosy. Arch Pathol, 1970; 89: 195-207.
3. Mukherjee R, Antia NH. Host-parasite interelationship between M. leprae and Schwann cells in vitro. Int J Lepr, 1986; 54: 632-638.
4. Mukherjee R, Mahadevan PR, Antia NH. Organised nerve culture. II. DNA synthesis in Schwann cells in the presence of M. leprae. Int J Lepr, 1980; 48: 189-192.
5. 14C-acetate into the specific phenolic glycolipid of M. leprae maintained within cultured cells. IRCS Med Sci, 1985; 13: 203-204.
6. Shetty VP, Mistry NF, Antia NH. Serum demyelinating factors and adjuvant-like activity of Mycobacterium leprae: Possible causes of early nerve damage in leprosy. Lepr Rev, 1985; 56: 221-227.
7. Wright DJM, Hirst RA, Waters MFR. Neural autoantibodies in leprosy. Lepr Rev, 1975; 46: 157-169.
8. Mshana RN, Harboe M, Stoner GL, Hughes RA, Kadlubowski M, Belehu A. Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein. Int J Lepr, 1983; 51: 33-40.
9. Eustis-Turf EP, Benjamins JA, Lefford MJ. Characterization of anti-neural antibodies in the sera of leprosy patients. J Neuroimmunol, 1986; 10: 313-330.
10. Thomas BM, Mukherjee R. Antineural antibodies in sera of leprosy patients. Clin Immunol Immunopathol, 1990; 57: 420-429.
11. Vemuri N, Mukherjee R. Immunoreactivity of nerve lipid antigens in leprosy. J Clin Lab Anal, 1991; 5: 157-161.
12. Cho SN, Gormus BJ, Xu K, Bohm RP Jr, Walsh GP, Meyers WM, Kim JD. Serologic responses to nerve antigens in Sooty Mangabey monkeys with experimental leprosy. Int J Lepr, 1993; 61: 236-244.
13. Zeballos RS, Fox RI, Cheresh DA, McPherson RA. Antiglycosphingolipid autoantibodies in rheumatologic disorders. J Clin Lab Anal, 1994; 8: 378-384.
14. Hosein ZZ, Gilbert JJ, Strejan GH. The role of myelin lipids in experimental allergic encephalomyelitis. Part 2. Influence of disease production by encephalitigenic doses of myelin basic protein. J Neuroimmunol, 1986; 10: 219-233.
15. Fry JM, Weissbarth S, Lehrer GM, Bornstein MB. Cerebroside antibody inhibits sulfatide synthesis and myelination and demyelinates in cord tissue culture. Science, 1974; 183: 225-248.
16. Raine CS, Johnson AB, Marcus DM, Suzuki A, Bornstein MB. Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target. N Neurol Sci, 1981; 52: 117-131.
17. Webb HE. Antiglycolipid autoimmunity Possible viral etiology of multiple sclerosis. In: S. Specter, M. Bendinelli and H. Friedman (Eds), Neuropathogenic viruses and immunity, Plenum Press, New York, 1992; 277-302.
18. Hruby S, Alvord EC, Seil FJ. Synthetic galactocerebrosides evoke myelination-inhibiting antibodies. Science, 1977; 195: 173-175.
19. Saida K, Saida T, Brown M, Siberberg D. In vivo demyelination induced by intraneural injection of antigalactocerebroside serum. Am J Pathol, 1979; 95: 99-116.
20. Sergott RC, Brown MJ, Silberberg D, Lisak RP. Antigalactocerebroside serum demyelinates optic nerve in vivo. J Neurol Sci, 1984; 64: 297-303.
21. Roth GA, Roytta M, Yu RK, Raine CS, Bornstein MB. Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures. Brain Res, 1985; 339: 9-18.
22. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science, 1993; 259: 1769-1771.